FindTrial
Sign In

The expression and clinical significance of opioid receptors and ligands in whole cancer were analyzed based on clinical bioinformatics methods

The expression and clinical significance of opioid receptors and ligands in whole cancer were analyzed based on clinical bioinformatics methods

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108480
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney renal clear cell carcinoma

Interventions

Trial group:None

Sponsors

The First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.18 years old to 80 years old 2. The pathological diagnosis is clear cell renal carcinoma 3.The specimen should be at least 1 centimeter in length, width and height

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
The expressions of OPRL1;The expressions of OPRD1;—

Countries

China

Contacts

Public ContactWang Jun

The First Affiliated Hospital of China Medical University

wangjuncmu@126.com+86 158 4037 7700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026